Tuesday, August 11, 2026

End of Deterrence: North Korea Claims New Hypersonic Missile Perfected To Nullify All US Strategic Assets

North Korea conducts its first ballistic missile test in over five months, prompting U.S. condemnation and regional security monitoring.

North Korea’s Legal Overhaul: What the Abolition of Preliminary Hearings Means for Human Rights in 2026

North Korea's judicial reforms aim for efficiency but raise concerns over human rights, potentially enhancing state control and privacy infringements.

Kim Jong Un and Vladimir Putin Sign New Pact

South Korea's Presidential Office remains tight-lipped about...

Tag: Hyundai BioScience

Hyundai Bioscience’s Xafty Clears Genotoxicity Study, Supporting U.S. Phase 2 Respiratory Virus Trial Plans

Hyundai Bioscience's Xafty shows no genotoxicity in tests, aiding its Phase 2 trial plans for respiratory viral infections.

How Hyundai BioScience’s XAFTY Could Revolutionize Ebola Treatment: A Free Supply Proposal

Hyundai Bio USA proposes to provide antiviral candidate XAFTY for free to Ebola-affected countries, aiming to combat the disease urgently.

Hyundai Bioscience Launches Global Clinical Trials for Dengue Treatment in Vietnam

Hyundai BioScience launches global clinical trials for a broad-spectrum antiviral treatment targeting dengue fever in Vietnam.

Top News

- Our Sponsors Ad -

Follow us